180 related articles for article (PubMed ID: 22137931)
1. Synthesis, anti-inflammatory activity and ulcerogenic liability of novel nitric oxide donating/chalcone hybrids.
Abuo-Rahma Gel-D; Abdel-Aziz M; Mourad MA; Farag HH
Bioorg Med Chem; 2012 Jan; 20(1):195-206. PubMed ID: 22137931
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and investigation of anti-inflammatory activity and gastric ulcerogenicity of novel nitric oxide-donating pyrazoline derivatives.
Shoman ME; Abdel-Aziz M; Aly OM; Farag HH; Morsy MA
Eur J Med Chem; 2009 Jul; 44(7):3068-76. PubMed ID: 18722034
[TBL] [Abstract][Full Text] [Related]
3. New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities.
Abdel-Aziz M; Abuo-Rahma Gel-D; Beshr EA; Ali TF
Bioorg Med Chem; 2013 Jul; 21(13):3839-49. PubMed ID: 23665142
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer activity of nitric oxide donating/chalcone hybrids.
Mourad MA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH
Eur J Med Chem; 2012 Aug; 54():907-13. PubMed ID: 22703846
[TBL] [Abstract][Full Text] [Related]
5. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
6. 1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activities.
Abuo-Rahma Gel-D; Abdel-Aziz M; Beshr EA; Ali TF
Eur J Med Chem; 2014 Jan; 71():185-98. PubMed ID: 24308998
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of some novel pyrazole derivatives as potential antiinflammatory agents with minimum ulcerogenic activity.
el-Hawash SA; el-Mallah AI
Pharmazie; 1998 Jun; 53(6):368-73. PubMed ID: 9675765
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-inflammatory activity of novel biscoumarin-chalcone hybrids.
Sashidhara KV; Kumar M; Modukuri RK; Sonkar R; Bhatia G; Khanna AK; Rai S; Shukla R
Bioorg Med Chem Lett; 2011 Aug; 21(15):4480-4. PubMed ID: 21723119
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs.
Bhandari SV; Dangre SC; Bothara KG; Patil AA; Sarkate AP; Lokwani DK; Gore ST; Deshmane BJ; Raparti VT; Khachane CV
Eur J Med Chem; 2009 Nov; 44(11):4622-36. PubMed ID: 19647903
[TBL] [Abstract][Full Text] [Related]
11. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE
J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945
[TBL] [Abstract][Full Text] [Related]
12. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives.
Bhandari SV; Parikh JK; Bothara KG; Chitre TS; Lokwani DK; Devale TL; Modhave NS; Pawar VS; Panda S
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):520-30. PubMed ID: 20109034
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide release is not required to decrease the ulcerogenic profile of nonsteroidal anti-inflammatory drugs.
Jain S; Tran S; El Gendy MA; Kashfi K; Jurasz P; Velázquez-Martínez CA
J Med Chem; 2012 Jan; 55(2):688-96. PubMed ID: 22148253
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological characterization of a novel nitric oxide-releasing diclofenac derivative containing a benzofuroxan moiety.
de Carvalho PS; Maróstica M; Gambero A; Pedrazzoli J
Eur J Med Chem; 2010 Jun; 45(6):2489-93. PubMed ID: 20227145
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives.
Amir M; Kumar S
Arch Pharm (Weinheim); 2005 Jan; 338(1):24-31. PubMed ID: 15674801
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives.
Nagarapu L; Mateti J; Gaikwad HK; Bantu R; Sheeba Rani M; Prameela Subhashini NJ
Bioorg Med Chem Lett; 2011 Jul; 21(14):4138-40. PubMed ID: 21689936
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluations of N-(substituted benzoylamino)-5-carbethoxymethyl-1,2,3,6-tetrahydropyridines as potential antiinflammatory agents.
Yoon K; Wilson T; Williams S; Redda K
Drugs Exp Clin Res; 2000; 26(3):73-82. PubMed ID: 10941599
[TBL] [Abstract][Full Text] [Related]
19. Analgesic, anti-inflammatory and antiulcer activity of nitric oxide releasing ester derivatives of indomethacin.
Vashist N; Singh J; Pathak DP
Indian J Physiol Pharmacol; 2010; 54(3):277-83. PubMed ID: 21409866
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological investigation of certain pyrazole-3-carboxylic acid derivatives as novel carriers for nitric oxide.
Abdel-Hafez el-SM; Abuo-Rahma Gel-D; Abdel-Aziz M; Radwan MF; Farag HH
Bioorg Med Chem; 2009 Jun; 17(11):3829-37. PubMed ID: 19419878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
